http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2244862-C
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5dfc0b033ac4c841466d97a5f28ea32b |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-68 |
| filingDate | 1997-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2006-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_715bf9b52e236d5d66cec00357565b85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e12efd08d80207e3284d2669173f201 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82ed778400e5d64cd17d4d1adc900b21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e32e01285b634a8ebc1787cf8e89ff28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdef9d58b9ef056e863573601c9863b9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e3c2810aebc5cc2c2a3535f0f186fb6 |
| publicationDate | 2006-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2244862-C |
| titleOfInvention | Substituted amide derivatives |
| abstract | The present invention relates to a compound represented by general formula (I) or a pharmaceutically acceptable salt or ester thereof: (see formula I) (wherein each of (see formula II) is an aryl group or an aromatic heterocyclic group; A1 is a C1-6 chain hydrocarbon group or a group represented by -A1a-W1-A1b- (wherein W1 is an oxygen atom, a sulfur atom, an ethynylene group, a cyclopropylene group or a group represented by -NR w-); A2 is a C1-8 chain hydrocarbon group; R1 is a lower alkyl group, a lower alkenyl group, a lower alkoxy group, a carboxyl group, a lower alkoxycarbonyl group, a carbamoyl group, a lower alkylcarbamoyl group, a group represented by R a COO- (wherein R a is a hydrogen atom, an amino group, a lower alkyl group, a lower alkoxy group or a lower alkylamino group) or by R b CONR c- (wherein R b is a hydrogen atom, an amino group, a lower alkyl group, a lower alkoxy group or a lower alkylamino group) or an alicyclic group; R2 is a lower alkyl group; and each of X and Y is an oxygen atom, 148 a sulfur atom, a carbonyl group, a group represented by -CHR d- or by -NR e-, or X and Y together represent a vinylene group or an ethynylene group, provided that when one of X and Y is an oxygen atom, a sulfur atom or group represented by -NR e-, the other is a carbonyl group or a group represented by -CHR d-] and an antitumor agent comprising it as an active ingredient. |
| priorityDate | 1996-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 334.